** Shares in the Belgian healthcare firm Fagron FAGRO.BR
jump 1.7% following a 3.3% rise in early trading after
"impressive" full-year results
** KBC ("buy") says Fagron's 2023 revenue, up 11.6% at 763
million euros ($818.93 million), beat of its estimates, showing
an "impressive growth"
** Fagron's compounding business in North America "crowns
the update with an astonishing 44.7% y/y growth," KBC adds
** Including today's rise, the stock has gained 7.16% YTD
($1 = 0.9317 euros)
(Reporting by Dagmarah Mackos)
((dagmarah.mackos@tr.com))